Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antiviralsAna Lleò, Massimo Colombo, Andrea Aglitti et al.|Digestive and Liver Disease|2018Cited by 63
High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinomaMarcello Persico, Savino Bruno, Andrea Aglitti et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 33
SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: a prospective multi-centric Italian studyAna Lleò, Savino Bruno, Andrea Aglitti et al.|Journal of Hepatology|2018Cited by 2
Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP surveySavino Bruno, V. Di Marco, Luisa Cavalletto et al.|Digestive and Liver Disease|2014Cited by 1
A multicentre prospective study response to treatment in genotype 3 and 1b infected patients with sickest liver cirrhosis: SVR 4 is not a reliable measureMarcello Persico, Savino Bruno, Maria Rendina et al.|Digestive and Liver Disease|2016Cited by 0